Epilepsy: new advances
Top Cited Papers
- 1 March 2015
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 385 (9971), 884-898
- https://doi.org/10.1016/s0140-6736(14)60456-6
Abstract
No abstract availableKeywords
This publication has 139 references indexed in Scilit:
- Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood AutismJAMA, 2013
- Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational studyThe Lancet Neurology, 2013
- Evidence of an inhibitory restraint of seizure activity in humansNature Communications, 2012
- Mutations affecting GABAergic signaling in seizures and epilepsyPflügers Archiv - European Journal of Physiology, 2010
- Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence EpilepsyNew England Journal of Medicine, 2010
- Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigenThe Lancet Neurology, 2009
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008
- The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- Adult epilepsyThe Lancet, 2006